全球造影超音波市场

到 2030 年，全球造影超音波市场规模将达到 27 亿美元

全球造影超音波市场规模预计在2024年为21亿美元，到2030年将达到27亿美元，2024年至2030年的复合年增长率为4.2% 。超音波设备是本报告分析的细分市场之一，预计其复合年增长率为5.1%，到分析期结束时规模将达到16亿美元。超音波显影剂细分市场在分析期间的复合年增长率预计为3.0%。

美国市场规模估计为 5.707 亿美元，中国市场预计复合年增长率为 7.8%

美国造影超音波市场规模预计在2024年达到5.707亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5.527亿美元，在分析期间（2024-2030年）的复合年增长率为7.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.6%和3.2%。在欧洲，预计德国的复合年增长率为2.4%。

全球造影超音波市场趋势与驱动因素

为什么造影超音波在医学影像中变得越来越重要？

超音波造影迅速改变医学影像领域，为CT和MRI等传统影像方式提供了更安全、更经济、更详细的替代方案。该技术利用微气泡显影剂增强了血流、血管结构和组织灌注的可视化，显着提高了各种临床应用中的诊断准确性。与通常难以区分相似组织密度的传统超音波不同，造影造影超音波能够提供灵敏度更高的即时成像，从而更好地检测肿瘤、发炎和缺血区域等异常情况。

推动造影超音波应用的关键因素之一是其安全性。 CT和MRI检查中使用的传统显影剂含有碘或钆，有过敏反应和肾毒性的风险，尤其对肾功能受损的患者。相较之下，基于微气泡的超音波显影剂具有生物惰性，可快速排放体外，安全性更高。此外，造影超音波不涉及电离辐射，是儿科和孕妇的首选。对非侵入性、无辐射诊断影像解决方案的需求日益增长，使得造影超音波成为现代诊断工作流程中的重要工具。

科技进步如何增强造影超音波？

超音波成像技术的进步显着提高了造影超音波的功能和准确性，使其能够更有效地检测和描述各种病理。其中最显着的创新之一是即时灌注成像的发展，它使临床医生能够评估微血管血流动力学，并更准确地识别组织和器官的异常。这在肿瘤学中尤其有用，因为增强对肿瘤血管的可视化有助于区分良性和恶性病变，并有助于早期癌症检测和治疗计划。

另一项重要进展是人工智慧和机器学习在造影超音波分析中的融合。人工智慧主导的影像解读演算法可以自动侦测和量化灌注模式的变化，减少对操作员的依赖，并提高诊断的一致性。此外，新一代超音波设备具有更高的空间解析度、更优的谐波成像和更强大的多普勒功能，进一步提升了造影超音波可视化血流和组织超音波的能力。这些技术进步使造影超音波成为精准医疗的重要工具，为各种病理提供量身定制的成像解决方案。

造影超音波的主要工业应用有哪些？

造影超音波彻底改变了临床医生诊断和监测疾病的方式，并在多个医学专业领域中得到越来越广泛的应用。其主要应用之一是肝病学，用于评估肝臟病变、肝硬化和肝臟灌注异常。造影超音波能够区分良性和恶性肝肿瘤，使其成为肝癌筛检的首选影像方式，尤其适用于慢性肝病患者。此外，它在指导肝臟切片检查和监测肝细胞癌患者的治疗反应方面也发挥着重要作用。

在心臟病学中，造影超音波被广泛用于评估心肌灌注、检测缺血性心臟疾病和评估心臟功能。透过可视化微血管血流，造影超音波可帮助心臟科医师检测出标准心臟超音波图无法发现的细微灌注障碍。造影超音波在肾臟科也越来越受欢迎，它可用于诊断肾臟疾病、评估肾臟灌注和检测血管异常。其他新兴应用包括肿瘤学，它有助于检测乳癌、前列腺癌和胰腺癌，以及肌肉骨骼成像，它可以评估发炎状况和软组织血管生成。随着医学界不断认识到造影超音波的益处，它的应用正在扩展到各种诊断和介入程序。

哪些因素推动了造影超音波市场的成长？

造影超音波市场的成长受到多种因素的推动，包括对非侵入性成像技术日益增长的需求、超音波技术的进步以及需要详细血管评估的慢性疾病盛行率的上升。随着医疗保健提供者寻求比CT和MRI更安全、更具成本效益的替代方案，造影超音波因其无辐射特性和高诊断准确性，正逐渐成为首选的影像方式。肝臟疾病、心血管疾病和癌症的盛行率不断上升，进一步推动了对先进影像解决方案的需求，使造影超音波成为疾病检测和管理的关键工具。

人工智慧与即时影像分析的融合正在提高造影超音波解读的准确性和效率，这是另一个关键驱动因素。携带式和照护现场超音波诊断设备的日益普及超音波诊断设备推动了市场成长，使其在急诊、重症患者和门诊病人中的应用更加广泛。造影超音波的监管核准和报销政策的不断扩大也推动了其在医疗保健提供者中的广泛应用。随着对即时高解析度影像的需求不断增长，造影超音波已成为现代医学诊断的重要组成部分，为广泛的临床应用提供更快、更安全、更准确的影像解决方案。

部分

产品类型（超音波设备、超音波显影剂）；CEUS 类型（非标靶 CEUS、标靶 CEUS）；最终用途（医院最终用途、诊所最终用途、门诊诊断中心最终用途）

受访公司范例

• Acusphere Inc.
• Alpinion Medical Systems
• BK Medical Holding Company Inc.
• Bracco Diagnostic Inc.
• Canon Medical Systems Corporation
• Chison Medical Technology Co., Ltd.
• ContextVision AB
• Esaote SpA
• FUJIFILM VisualSonics Inc.
• GE Healthcare
• Hitachi Healthcare
• Koninklijke Philips NV
• Lantheus Medical Imaging, Inc.
• Leriva Pharma SA
• nanoPET Pharma GmbH
• Samsung Healthcare
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers
• Trivitron Healthcare Pvt. Ltd.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定产业的SLM，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Contrast Enhanced Ultrasound Market to Reach US$2.7 Billion by 2030

The global market for Contrast Enhanced Ultrasound estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Ultrasound Equipment, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Ultrasound Contrast Agents segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$570.7 Million While China is Forecast to Grow at 7.8% CAGR

The Contrast Enhanced Ultrasound market in the U.S. is estimated at US$570.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$552.7 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Contrast-Enhanced Ultrasound Market - Trends, Innovations & Growth Drivers

Why Is Contrast-Enhanced Ultrasound Gaining Importance in Medical Imaging?

Contrast-enhanced ultrasound is rapidly transforming the field of medical imaging, offering a safer, cost-effective, and highly detailed diagnostic alternative to traditional imaging modalities such as CT and MRI. By using microbubble contrast agents, this technology enhances the visualization of blood flow, vascular structures, and tissue perfusion, significantly improving diagnostic accuracy in various clinical applications. Unlike conventional ultrasound, which often struggles to differentiate between similar tissue densities, contrast-enhanced ultrasound provides real-time imaging with higher sensitivity, allowing for better detection of abnormalities such as tumors, inflammation, and ischemic regions.

One of the major factors driving the adoption of contrast-enhanced ultrasound is its safety profile. Traditional contrast agents used in CT and MRI scans contain iodine and gadolinium, which pose risks of allergic reactions and nephrotoxicity, especially in patients with kidney dysfunction. In contrast, microbubble-based ultrasound contrast agents have an excellent safety record, as they are biologically inert and quickly eliminated from the body. Additionally, contrast-enhanced ultrasound does not involve ionizing radiation, making it a preferred choice for pediatric and pregnant patients. The demand for non-invasive, radiation-free imaging solutions is increasing, making contrast-enhanced ultrasound a valuable tool in modern diagnostic workflows.

How Are Technological Advancements Enhancing Contrast-Enhanced Ultrasound?

Advancements in ultrasound imaging technology have significantly improved the capabilities and accuracy of contrast-enhanced ultrasound, making it more effective in detecting and characterizing various pathologies. One of the most notable innovations is the development of real-time perfusion imaging, which allows clinicians to assess microvascular blood flow dynamics and identify abnormalities in tissues and organs with greater precision. This is particularly useful in oncology, where enhanced visualization of tumor vascularity can help differentiate between benign and malignant lesions, aiding in early cancer detection and treatment planning.

Another key advancement is the integration of artificial intelligence and machine learning in contrast-enhanced ultrasound analysis. AI-driven image interpretation algorithms can automatically detect and quantify changes in perfusion patterns, reducing operator dependency and improving diagnostic consistency. Additionally, new-generation ultrasound machines feature higher spatial resolution, improved harmonic imaging, and enhanced Doppler capabilities, further refining contrast-enhanced ultrasound’s ability to visualize blood flow and tissue perfusion. With these technological improvements, contrast-enhanced ultrasound is becoming an essential tool in precision medicine, offering tailored imaging solutions for various medical conditions.

What Are the Key Industry Applications of Contrast-Enhanced Ultrasound?

Contrast-enhanced ultrasound is being increasingly utilized across multiple medical specialties, revolutionizing the way clinicians diagnose and monitor diseases. One of the primary applications is in hepatology, where it is used to assess liver lesions, cirrhosis, and hepatic perfusion abnormalities. The ability of contrast-enhanced ultrasound to differentiate between benign and malignant liver tumors has made it a preferred imaging method in liver cancer screening, particularly for patients with chronic liver disease. Additionally, it plays a critical role in guiding liver biopsies and monitoring treatment response in hepatocellular carcinoma patients.

In cardiology, contrast-enhanced ultrasound is widely used for evaluating myocardial perfusion, detecting ischemic heart disease, and assessing cardiac function. By enhancing the visualization of microvascular blood flow, it helps cardiologists detect subtle perfusion defects that may not be visible on standard echocardiography. Contrast-enhanced ultrasound is also gaining traction in nephrology, where it assists in diagnosing kidney diseases, assessing renal perfusion, and detecting vascular abnormalities. Other emerging applications include oncology, where it aids in the detection of breast, prostate, and pancreatic cancers, as well as musculoskeletal imaging for evaluating inflammatory conditions and soft tissue vascularization. As the medical community continues to recognize the advantages of contrast-enhanced ultrasound, its use is expanding across various diagnostic and interventional procedures.

What Factors Are Driving Growth in the Contrast-Enhanced Ultrasound Market?

The growth in the contrast-enhanced ultrasound market is driven by several factors, including increasing demand for non-invasive imaging techniques, advancements in ultrasound technology, and the growing prevalence of chronic diseases requiring detailed vascular assessment. As healthcare providers seek safer and more cost-effective alternatives to CT and MRI, contrast-enhanced ultrasound is emerging as a preferred imaging modality due to its radiation-free nature and high diagnostic accuracy. The rising incidence of liver disease, cardiovascular disorders, and cancer has further accelerated the need for advanced imaging solutions, positioning contrast-enhanced ultrasound as a critical tool in disease detection and management.

Another key driver is the integration of artificial intelligence and real-time image analysis, which is enhancing the accuracy and efficiency of contrast-enhanced ultrasound interpretation. The increasing adoption of portable and point-of-care ultrasound systems is also fueling market growth, allowing for broader accessibility in emergency medicine, critical care, and outpatient settings. Additionally, regulatory approvals and expanded reimbursement policies for contrast-enhanced ultrasound procedures are encouraging greater adoption among healthcare providers. As the demand for real-time, high-resolution imaging continues to grow, contrast-enhanced ultrasound is set to become an indispensable part of modern medical diagnostics, providing faster, safer, and more precise imaging solutions across a wide range of clinical applications.

SCOPE OF STUDY:

The report analyzes the Contrast Enhanced Ultrasound market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Ultrasound Equipment, Ultrasound Contrast Agents); CEUS Type (Non-Targeted CEUS, Targeted CEUS); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Diagnostic Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Acusphere Inc.
• Alpinion Medical Systems
• BK Medical Holding Company Inc.
• Bracco Diagnostic Inc.
• Canon Medical Systems Corporation
• Chison Medical Technology Co., Ltd.
• ContextVision AB
• Esaote S.p.A.
• FUJIFILM VisualSonics Inc.
• GE Healthcare
• Hitachi Healthcare
• Koninklijke Philips N.V.
• Lantheus Medical Imaging, Inc.
• Leriva Pharma S.A.
• nanoPET Pharma GmbH
• Samsung Healthcare
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers
• Trivitron Healthcare Pvt. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Contrast Enhanced Ultrasound - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Liver, Kidney, and Cardiovascular Diseases Drives Clinical Adoption of CEUS
  • Radiation-Free Imaging Alternatives Strengthen the Business Case for Contrast-Enhanced Ultrasound Over CT and MRI
  • Increased Use of CEUS in Oncology Supports Demand for Real-Time, Non-Invasive Tumor Characterization
  • FDA and EMA Approvals for New Contrast Agents Expand Clinical Applications Across Regions
  • Advancements in Microbubble Contrast Agents Enhance Image Resolution and Diagnostic Accuracy
  • Growing Awareness Among Radiologists and Sonographers Boosts Utilization Rates in Hospitals and Imaging Centers
  • Demand for Bedside and Point-of-Care Diagnostics Propels CEUS Use in Emergency and Critical Care Settings
  • Pediatric and Pregnant Patient Populations Drive Need for Safer, Non-Ionizing Imaging Modalities
  • Healthcare Cost Optimization Goals Promote CEUS as a Lower-Cost Alternative to Cross-Sectional Imaging
  • Clinical Expansion Into Cardiac, Vascular, and GI Imaging Broadens the CEUS Use Case Portfolio
  • OEM Innovations in Ultrasound Systems With CEUS Capabilities Improve Workflow Integration
  • CEUS-Guided Biopsies and Interventional Procedures Enhance Clinical Outcomes and Expand Adoption
  • Increased Use in Chronic Disease Management and Monitoring Drives Repeat Imaging Demand
  • Supportive Reimbursement Structures in Europe and Select U.S. States Accelerate Institutional Adoption
  • Growing Preference for Portable and Handheld Ultrasound Devices Expands CEUS Accessibility
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Contrast Enhanced Ultrasound Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Contrast Enhanced Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Ultrasound Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Ultrasound Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ultrasound Contrast Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ultrasound Contrast Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Ultrasound Contrast Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Non-Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Non-Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Non-Targeted CEUS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Targeted CEUS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ambulatory Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Ambulatory Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• JAPAN
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• CHINA
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: China 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• EUROPE
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Contrast Enhanced Ultrasound by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• FRANCE
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• GERMANY
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: UK 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• INDIA
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: India 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
• AFRICA
  • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION